1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Medication Revenue
• 1.4 Market by Type
  • 1.4.1 Global Medication Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Brand Drugs
  • 1.4.3 Generic Drug
• 1.5 Market by Application
  • 1.5.1 Global Medication Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Medication Market Perspective (2015-2026)
• 2.2 Global Medication Growth Trends by Regions
  • 2.2.1 Medication Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Medication Historic Market Share by Regions (2015-2020)
  • 2.2.3 Medication Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Medication Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Medication Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Medication Players by Market Size
  • 3.1.1 Global Top Medication Players by Revenue (2015-2020)
  • 3.1.2 Global Medication Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Medication Market Concentration Ratio
  • 3.2.1 Global Medication Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2019
• 3.3 Medication Key Players Head office and Area Served
• 3.4 Key Players Medication Product Solution and Service
• 3.5 Date of Enter into Medication Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Medication Historic Market Size by Type (2015-2020)
• 4.2 Global Medication Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Medication Market Size by Application (2015-2020)
• 5.2 Global Medication Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Medication Market Size (2015-2020)
• 6.2 Medication Key Players in North America (2019-2020)
• 6.3 North America Medication Market Size by Type (2015-2020)
• 6.4 North America Medication Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Medication Market Size (2015-2020)
• 7.2 Medication Key Players in Europe (2019-2020)
• 7.3 Europe Medication Market Size by Type (2015-2020)
• 7.4 Europe Medication Market Size by Application (2015-2020)

8 China

• 8.1 China Medication Market Size (2015-2020)
• 8.2 Medication Key Players in China (2019-2020)
• 8.3 China Medication Market Size by Type (2015-2020)
• 8.4 China Medication Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Medication Market Size (2015-2020)
• 9.2 Medication Key Players in Japan (2019-2020)
• 9.3 Japan Medication Market Size by Type (2015-2020)
• 9.4 Japan Medication Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Medication Market Size (2015-2020)
• 10.2 Medication Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Medication Market Size by Type (2015-2020)
• 10.4 Southeast Asia Medication Market Size by Application (2015-2020)

11 India

• 11.1 India Medication Market Size (2015-2020)
• 11.2 Medication Key Players in India (2019-2020)
• 11.3 India Medication Market Size by Type (2015-2020)
• 11.4 India Medication Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Medication Market Size (2015-2020)
• 12.2 Medication Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Medication Market Size by Type (2015-2020)
• 12.4 Central & South America Medication Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview
  • 13.1.3 Pfizer Medication Introduction
  • 13.1.4 Pfizer Revenue in Medication Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche Medication Introduction
  • 13.2.4 Roche Revenue in Medication Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Sanofi
  • 13.3.1 Sanofi Company Details
  • 13.3.2 Sanofi Business Overview
  • 13.3.3 Sanofi Medication Introduction
  • 13.3.4 Sanofi Revenue in Medication Business (2015-2020)
  • 13.3.5 Sanofi Recent Development
• 13.4 Johnson & Johnson
  • 13.4.1 Johnson & Johnson Company Details
  • 13.4.2 Johnson & Johnson Business Overview
  • 13.4.3 Johnson & Johnson Medication Introduction
  • 13.4.4 Johnson & Johnson Revenue in Medication Business (2015-2020)
  • 13.4.5 Johnson & Johnson Recent Development
• 13.5 Merck & Co. (MSD)
  • 13.5.1 Merck & Co. (MSD) Company Details
  • 13.5.2 Merck & Co. (MSD) Business Overview
  • 13.5.3 Merck & Co. (MSD) Medication Introduction
  • 13.5.4 Merck & Co. (MSD) Revenue in Medication Business (2015-2020)
  • 13.5.5 Merck & Co. (MSD) Recent Development
• 13.6 Novartis
  • 13.6.1 Novartis Company Details
  • 13.6.2 Novartis Business Overview
  • 13.6.3 Novartis Medication Introduction
  • 13.6.4 Novartis Revenue in Medication Business (2015-2020)
  • 13.6.5 Novartis Recent Development
• 13.7 AbbVie
  • 13.7.1 AbbVie Company Details
  • 13.7.2 AbbVie Business Overview
  • 13.7.3 AbbVie Medication Introduction
  • 13.7.4 AbbVie Revenue in Medication Business (2015-2020)
  • 13.7.5 AbbVie Recent Development
• 13.8 Gilead Sciences
  • 13.8.1 Gilead Sciences Company Details
  • 13.8.2 Gilead Sciences Business Overview
  • 13.8.3 Gilead Sciences Medication Introduction
  • 13.8.4 Gilead Sciences Revenue in Medication Business (2015-2020)
  • 13.8.5 Gilead Sciences Recent Development
• 13.9 GlaxoSmithKline (GSK)
  • 13.9.1 GlaxoSmithKline (GSK) Company Details
  • 13.9.2 GlaxoSmithKline (GSK) Business Overview
  • 13.9.3 GlaxoSmithKline (GSK) Medication Introduction
  • 13.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2015-2020)
  • 13.9.5 GlaxoSmithKline (GSK) Recent Development
• 13.10 Amgen
  • 13.10.1 Amgen Company Details
  • 13.10.2 Amgen Business Overview
  • 13.10.3 Amgen Medication Introduction
  • 13.10.4 Amgen Revenue in Medication Business (2015-2020)
  • 13.10.5 Amgen Recent Development
• 13.11 AstraZeneca
  • 10.11.1 AstraZeneca Company Details
  • 10.11.2 AstraZeneca Business Overview
  • 10.11.3 AstraZeneca Medication Introduction
  • 10.11.4 AstraZeneca Revenue in Medication Business (2015-2020)
  • 10.11.5 AstraZeneca Recent Development
• 13.12 Bristol-Myers Squibb
  • 10.12.1 Bristol-Myers Squibb Company Details
  • 10.12.2 Bristol-Myers Squibb Business Overview
  • 10.12.3 Bristol-Myers Squibb Medication Introduction
  • 10.12.4 Bristol-Myers Squibb Revenue in Medication Business (2015-2020)
  • 10.12.5 Bristol-Myers Squibb Recent Development
• 13.13 Eli Lilly
  • 10.13.1 Eli Lilly Company Details
  • 10.13.2 Eli Lilly Business Overview
  • 10.13.3 Eli Lilly Medication Introduction
  • 10.13.4 Eli Lilly Revenue in Medication Business (2015-2020)
  • 10.13.5 Eli Lilly Recent Development
• 13.14 Teva
  • 10.14.1 Teva Company Details
  • 10.14.2 Teva Business Overview
  • 10.14.3 Teva Medication Introduction
  • 10.14.4 Teva Revenue in Medication Business (2015-2020)
  • 10.14.5 Teva Recent Development
• 13.15 Bayer
  • 10.15.1 Bayer Company Details
  • 10.15.2 Bayer Business Overview
  • 10.15.3 Bayer Medication Introduction
  • 10.15.4 Bayer Revenue in Medication Business (2015-2020)
  • 10.15.5 Bayer Recent Development
• 13.16 Novo Nordisk
  • 10.16.1 Novo Nordisk Company Details
  • 10.16.2 Novo Nordisk Business Overview
  • 10.16.3 Novo Nordisk Medication Introduction
  • 10.16.4 Novo Nordisk Revenue in Medication Business (2015-2020)
  • 10.16.5 Novo Nordisk Recent Development
• 13.17 Allergan
  • 10.17.1 Allergan Company Details
  • 10.17.2 Allergan Business Overview
  • 10.17.3 Allergan Medication Introduction
  • 10.17.4 Allergan Revenue in Medication Business (2015-2020)
  • 10.17.5 Allergan Recent Development
• 13.18 Takeda
  • 10.18.1 Takeda Company Details
  • 10.18.2 Takeda Business Overview
  • 10.18.3 Takeda Medication Introduction
  • 10.18.4 Takeda Revenue in Medication Business (2015-2020)
  • 10.18.5 Takeda Recent Development
• 13.19 Boehringer Ingelheim
  • 10.19.1 Boehringer Ingelheim Company Details
  • 10.19.2 Boehringer Ingelheim Business Overview
  • 10.19.3 Boehringer Ingelheim Medication Introduction
  • 10.19.4 Boehringer Ingelheim Revenue in Medication Business (2015-2020)
  • 10.19.5 Boehringer Ingelheim Recent Development
• 13.20 Takeda
  • 10.20.1 Takeda Company Details
  • 10.20.2 Takeda Business Overview
  • 10.20.3 Takeda Medication Introduction
  • 10.20.4 Takeda Revenue in Medication Business (2015-2020)
  • 10.20.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda

Market segment by Type, the product can be split into
Brand Drugs
Generic Drug
Market segment by Application, split into
Hospital
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America